Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond

S Bittner, T Hehlgans, M Feuerer - Trends in Immunology, 2023 - cell.com
Regulatory T (Treg) cells ensure tolerance against self-antigens, limit excessive
inflammation, and support tissue repair processes. Therefore, Treg cells are currently …

Eras of designer Tregs: Harnessing synthetic biology for immune suppression

K Tuomela, K Salim, MK Levings - Immunological Reviews, 2023 - Wiley Online Library
Since their discovery, CD4+ CD25hiFOXP3hi regulatory T cells (Tregs) have been firmly
established as a critical cell type for regulating immune homeostasis through a plethora of …

Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation

E Proics, M David, M Mojibian, M Speck… - Gene Therapy, 2023 - nature.com
A primary goal in transplantation medicine is the induction of a tolerogenic environment for
prevention of transplant rejection without the need for long-term pharmacological …

Regulatory T lymphocytes as a therapy for ischemic stroke

M Wang, AW Thomson, F Yu, R Hazra… - Seminars in …, 2023 - Springer
Unrestrained excessive inflammatory responses exacerbate ischemic brain injury and
impede post-stroke brain recovery. CD4+ CD25+ Foxp3+ regulatory T (Treg) cells play …

[HTML][HTML] Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection

I Rosado-Sánchez, M Haque, K Salim, M Speck… - JCI insight, 2023 - ncbi.nlm.nih.gov
Tregs expressing chimeric antigen receptors (CAR-Tregs) are a promising tool to promote
transplant tolerance. The relationship between CAR structure and Treg function was studied …

Manufacturing next-generation regulatory T-cell therapies

KN MacDonald, K Salim, MK Levings - Current opinion in biotechnology, 2022 - Elsevier
Highlights•'Next generation'Treg cell therapy products will use genetic engineering to
enhance function.•Methods to scale up Treg cell therapy products depend on cell source …

Chimeric antigen receptor T cell and regulatory T cell therapy in non-oncology diseases: A narrative review of studies from 2017 to 2023

MY Sun, W Li, W Chen - Human Vaccines & Immunotherapeutics, 2023 - Taylor & Francis
Recently, the remarkable success of chimeric antigen receptor T cell (CAR-T) therapy in
treating certain tumors has led to numerous studies exploring its potential application to treat …

Promises and pitfalls of next-generation Treg adoptive immunotherapy

P Christofi, C Pantazi, N Psatha, I Sakellari, E Yannaki… - Cancers, 2023 - mdpi.com
Simple Summary Adoptive immunotherapy has emerged as an effective alternative of
mounting impact to the current standard of care in cancer, viral infections, and recently …

Chimerism-based tolerance induction in clinical transplantation: its foundations and mechanisms

K Mengrelis, M Muckenhuber, T Wekerle - Transplantation, 2023 - journals.lww.com
Hematopoietic chimerism remains the most promising strategy to bring transplantation
tolerance into clinical routine. The concept of chimerism-based tolerance aims to extend the …

Unlocking the potential of Tregs: innovations in CAR technology

CJ Requejo Cier, N Valentini… - Frontiers in Molecular …, 2023 - frontiersin.org
Regulatory T cells (Tregs) adoptive immunotherapy is emerging as a viable treatment option
for both autoimmune and alloimmune diseases. However, numerous challenges remain …